These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 19796568)

  • 1. Abstracts of the 10th International Workshop on Scleroderma Research. Cambridge, United Kingdom. August 2-6, 2008.
    Clin Exp Rheumatol; 2009; 27(3 Suppl 54):72-85. PubMed ID: 19796568
    [No Abstract]   [Full Text] [Related]  

  • 2. Abstracts of the 11th International Workshop on Scleroderma Research. August 1-4, 2010. Boston, Massachusetts, USA.
    Clin Exp Rheumatol; 2010; 28(5 Suppl 62):S57-82. PubMed ID: 21050547
    [No Abstract]   [Full Text] [Related]  

  • 3. Abstracts of the International Association of Biomedical Gerontology 10th Congress. 19-23 September 2003, Cambridge, United Kingdom.
    Biogerontology; 2003; 4 Suppl 1():1-107. PubMed ID: 14558513
    [No Abstract]   [Full Text] [Related]  

  • 4. Experimental Biology 2000--Milestones and Goals. Society for Experimental Biology annual symposium and joint international meeting. Cambridge, United Kingdom. 30 July-3 August 2000. Abstracts.
    Comp Biochem Physiol B Biochem Mol Biol; 2000 Jul; 126 Suppl 1():S1-108. PubMed ID: 11039099
    [No Abstract]   [Full Text] [Related]  

  • 5. Report and abstracts of the Fourth International Workshop on Human Chromosome 22 mapping 1994. Cambridge, United Kingdom, July 2-4, 1994.
    Scambler PJ
    Cytogenet Cell Genet; 1994; 67(4):277-94. PubMed ID: 7924454
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical trial design in scleroderma: where are we and where do we go next?
    Chung L; Denton CP; Distler O; Furst DE; Khanna D; Merkel PA;
    Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S97-102. PubMed ID: 22691217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Second International Workshop on Scleroderma Research.
    Korn JH; Black C
    Matrix; 1993 Sep; 13(5):427-9. PubMed ID: 8246838
    [No Abstract]   [Full Text] [Related]  

  • 8. International Symposium on Systemic Sclerosis. September 16-17, 2000. Abstracts.
    Z Rheumatol; 2001 Aug; 60(4):270-87. PubMed ID: 11724019
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevalence of scleroderma in Spain: an approach for estimating rare disease prevalence using a disease model.
    Villaverde-Hueso A; de la Paz MP; Martín-Arribas MC; Sánchez-Valle E; Ramírez-González A; Biairdi P
    Pharmacoepidemiol Drug Saf; 2008 Nov; 17(11):1100-7. PubMed ID: 18816486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abstracts of the 10th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV. London, United Kingdom. November 6-8, 2008.
    Antivir Ther; 2008; 13(8):A3-92. PubMed ID: 19350735
    [No Abstract]   [Full Text] [Related]  

  • 11. Measures of systemic sclerosis (scleroderma): Health Assessment Questionnaire (HAQ) and Scleroderma HAQ (SHAQ), physician- and patient-rated global assessments, Symptom Burden Index (SBI), University of California, Los Angeles, Scleroderma Clinical Trials Consortium Gastrointestinal Scale (UCLA SCTC GIT) 2.0, Baseline Dyspnea Index (BDI) and Transition Dyspnea Index (TDI) (Mahler's Index), Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR), and Raynaud's Condition Score (RCS).
    Pope J
    Arthritis Care Res (Hoboken); 2011 Nov; 63 Suppl 11():S98-111. PubMed ID: 22588774
    [No Abstract]   [Full Text] [Related]  

  • 12. Selected papers from the 10th International Conference on Polymers in Medicine and Surgery. September, 2004. Cambridge, United Kingdom.
    J Mater Sci Mater Med; 2006 Dec; 17(12):1191-296. PubMed ID: 17143748
    [No Abstract]   [Full Text] [Related]  

  • 13. Abstracts of Strategies for Engineered Negligible Senescence (SENS) Fifth Conference. August 31-September 4, 2011. Cambridge, United Kingdom.
    Rejuvenation Res; 2011 Aug; 14 Suppl 1():S11-45. PubMed ID: 21847798
    [No Abstract]   [Full Text] [Related]  

  • 14. Social/economic costs and health-related quality of life in patients with scleroderma in Europe.
    López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Kanavos P; Taruscio D; Schieppati A; Iskrov G; Péntek M; Delgado C; von der Schulenburg JM; Persson U; Chevreul K; Fattore G;
    Eur J Health Econ; 2016 Apr; 17 Suppl 1():109-17. PubMed ID: 27038626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Systemic sclerosis (scleroderma) without scleroderma].
    Nadashkevych ON
    Lik Sprava; 2001; (3):93-4. PubMed ID: 11560041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient perception of UK scleroderma services--results of an anonymous questionnaire.
    Mawdsley AH
    Rheumatology (Oxford); 2006 Dec; 45(12):1573. PubMed ID: 17043046
    [No Abstract]   [Full Text] [Related]  

  • 17. Scleroderma in children: emerging management issues.
    Panda S
    Indian J Dermatol Venereol Leprol; 2010; 76(4):348-56. PubMed ID: 20657114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies for engineered negligible senescence. Why genuine control of aging may be foreseeable. Proceedings of the 10th Congress of the International Association of Biomedical Gerontology (IABG). September 19-23, 2003. Cambridge, United Kingdom.
    Ann N Y Acad Sci; 2004 Jun; 1019():xv-xvi; 1-592. PubMed ID: 15320311
    [No Abstract]   [Full Text] [Related]  

  • 19. Scleroderma renal crisis precipitated by steroid treatment in systemic lupus erythematosus and scleroderma overlap syndrome.
    Alayoud A; Qamouss O; Hamzi A; Benyahia M; Oualim Z
    Arab J Nephrol Transplant; 2012 Sep; 5(3):153-7. PubMed ID: 22967254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generalized scleroderma (systemic scleroderma).
    TALBOTT JH
    Seminar; 1955; 17(3):21-5. PubMed ID: 13324328
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.